MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson's and Alzheimer's diseases at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.
A method for detecting early signs of Alzheimer’s disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. This is the conclusion of a new Lund University study - the most thorough and extensive undertaken in the field so far.
The underlying cause of most brain diseases are yet largely unknown. The clumping together of certain proteins is, however, a well-documented key step in the degradation of brain structures in Parkinson’s disease (PD), Alzheimer’s disease (AD) and Multiple system atrophy (MSA). For example, the protein alpha-synuclein is a known culprit in PD and MSA. A recent study from Lund University shows that this protein is naturally produced in a certain type of the brain’s helper cells, namely the oligodendrocytes. Since very little is known about the role of alpha-synuclein in these glial cells, this discovery should open up new lines of research on the part they may play during in disease progression, particularly in MSA.
Making your name as a scientist, building a career in research, is with very few exceptions a crooked path, especially if you start from scratch. The constant, fierce competition over grants, the fear of being scooped, fighting for positions and the permanent risk of having to uproot your family, are all good reasons to wear a furrowed brow. It is a lifestyle not suited for the faint-hearted. A couple of weeks ago Laurent Roybon received a letter confirming his appointment as associate professor. I sat down and talked to him about his journey as a scientist, a journey that has seen him return from across the Atlantic, only to end up in the very same office where he once sweated over his soon-due doctorate thesis.
On April 10th MultiPark and Parkinson Skåne invited the public to a full-day event aimed at raising awareness about Parkinson’s and the research dedicated towards the disease. The event was tied to the World Parkinson Day, which took place the following day. MultiPark scientists Malin Parmar and Tomas Björklund discussed approaching clinical trials in the fields of cell therapy and gene therapy. Young scientists participated in a lively Science Slam contest where they gave brief popular science talks hoping to grab the audience’s attention as they battled for first prize.
On April 10th MultiPark invites the public to a full-day event aimed at raising awareness about Parkinson's and the research dedicated towards the disease. MultiPark scientists Malin Parmar and Tomas Björklund will discuss looming clinical trials in the fields of cell therapy and gene therapy respectively. Young scienctists will participate in a Science Slam-contest where they will give brief popular science talks hoping to catch the attention of the audience. Radio host and actor Fredrik Ekblad will share his journey since being diagnosed with Parkinson's disease a couple of years ago. The day concludes with a panel Q&A.